SCS Hf 10 Burst denied as not medically necessary by Aetna?

Aetna's specific coverage criteria for scs hf10 burst are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies HF10/Burst SCS on Medical-Necessity Grounds

Aetna's medical-necessity denial for high-frequency (HF10) or burst-pattern spinal cord stimulation typically occurs when the submitted clinical record does not satisfy the criteria in Aetna's published medical policy for spinal cord stimulation. Common gaps include: insufficient documentation of a qualifying pain diagnosis; inadequate evidence that conservative and less-invasive treatments were tried and failed over a sufficient period; missing psychological evaluation or clearance; no documentation of a successful trial stimulation; or a prescriber workup that does not address the specific criteria Aetna requires before authorizing permanent implantation.

## Why This Denial Is Appealable

Spinal cord stimulation — including HF10 and burst modalities — is a recognized, FDA-cleared treatment for specific chronic pain conditions and is endorsed by the applicable pain medicine and neuromodulation specialty society guidelines. A medical-necessity denial does not mean the treatment is wrong for the patient; it means the submitted documentation did not make the case clearly enough. That is correctable with a well-structured appeal.

## Federal Appeal Framework

• Internal appeal: File within your plan's deadline (typically 180 days from denial). Aetna must issue a decision within 30 days for non-urgent pre-service requests.
• Peer-to-peer review: Before the formal appeal decision, the implanting physician should request a peer-to-peer call with Aetna's medical reviewer. Many medical-necessity SCS denials are reversed at this stage when the clinical picture is explained directly.
• External review (ACA §2719 / ERISA §503): If internal appeal fails, request IRO review within 4 months of the final denial. The IRO independently evaluates whether Aetna's criteria were applied appropriately.
• Expedited review: Available when the patient's pain condition constitutes a clinical urgency (e.g., significant functional impairment or risk of clinical deterioration).

## Documentation to Gather

1. Qualifying diagnosis records — specialist records (pain management, neurosurgery, neurology) establishing the specific chronic pain diagnosis, its duration, and clinical severity. 2. Conservative treatment failure history — dated records of all prior treatments with documented outcomes: medications, physical therapy, interventional procedures, and the clinical reason each was insufficient. 3. Psychological evaluation — a completed psychological or psychiatric clearance evaluation, which Aetna's policy typically requires before SCS implantation. 4. Trial stimulation report — if a trial stimulation was performed, the physician's report documenting the trial outcome, including the degree of pain relief and functional improvement observed. 5. Prescriber medical-necessity letter — a comprehensive letter from the implanting physician or referring pain specialist addressing each of Aetna's coverage criteria sequentially.

## Criteria-Mapping Strategy

Obtain Aetna's published medical policy for spinal cord stimulation. List every coverage criterion. For each one, cite the specific chart note, evaluation, or test result that satisfies it — with the date and provider name. Submit this as a structured, point-by-point response so the reviewer can verify each requirement without inference. Include relevant FDA clearance documentation for the specific device and indication.